Celldex Therapeutics Inc (CLDX) — Cash Flow-to-Debt Ratio
Celldex Therapeutics Inc (CLDX) has a Cash Flow-to-Debt Ratio of -1.19x as of March 2026, meaning its operating cash flow of $-65.59 Million could theoretically repay -1% of its total liabilities ($55.03 Million) in one year. See CLDX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Celldex Therapeutics Inc Cash Flow-to-Debt Ratio (1986–2025)
Historical debt coverage capacity for Celldex Therapeutics Inc across 39 annual periods. For the full cash flow conversion analysis, see Celldex Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Celldex Therapeutics Inc (1986–2025)
Year-by-year debt coverage analysis for Celldex Therapeutics Inc. Check Celldex Therapeutics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.78x | $-210.94 Million | $55.82 Million | ▼ -8.6% |
| 2024 | -3.48x | $-157.78 Million | $45.34 Million | ▼ -18.3% |
| 2023 | -2.94x | $-107.29 Million | $36.46 Million | ▲ +24.7% |
| 2022 | -3.91x | $-103.73 Million | $26.53 Million | ▼ -61.6% |
| 2021 | -2.42x | $-60.91 Million | $25.18 Million | ▼ -58.6% |
| 2020 | -1.53x | $-40.40 Million | $26.48 Million | ▲ +5.0% |
| 2019 | -1.61x | $-46.41 Million | $28.91 Million | ▲ +32.2% |
| 2018 | -2.37x | $-75.23 Million | $31.75 Million | ▼ -87.9% |
| 2017 | -1.26x | $-99.93 Million | $79.25 Million | ▼ -31.5% |
| 2016 | -0.96x | $-113.04 Million | $117.93 Million | ▲ +54.0% |
| 2015 | -2.08x | $-98.89 Million | $47.48 Million | ▲ +25.4% |
| 2014 | -2.79x | $-101.54 Million | $36.35 Million | ▼ -12.7% |
| 2013 | -2.48x | $-67.67 Million | $27.30 Million | ▼ -48.2% |
| 2012 | -1.67x | $-49.78 Million | $29.77 Million | ▼ -37.3% |
| 2011 | -1.22x | $-35.66 Million | $29.27 Million | ▼ -39.1% |
| 2010 | -0.88x | $-30.37 Million | $34.69 Million | ▼ -95.2% |
| 2009 | -0.45x | $-29.87 Million | $66.60 Million | ▼ -226.7% |
| 2008 | 0.35x | $18.28 Million | $51.66 Million | ▲ +203.9% |
| 2007 | -0.34x | $-19.30 Million | $56.69 Million | ▼ -174.8% |
| 2006 | 0.46x | $27.00 Million | $59.32 Million | ▲ +217.7% |
| 2005 | -0.39x | $-6.02 Million | $15.56 Million | ▲ +72.4% |
| 2004 | -1.40x | $-10.35 Million | $7.40 Million | ▲ +59.7% |
| 2003 | -3.47x | $-11.74 Million | $3.39 Million | ▲ +19.1% |
| 2002 | -4.28x | $-16.66 Million | $3.89 Million | ▼ -69.0% |
| 2001 | -2.53x | $-20.83 Million | $8.22 Million | ▼ -450.8% |
| 2000 | -0.46x | $-4.43 Million | $9.63 Million | ▲ +86.7% |
| 1999 | -3.46x | $-8.54 Million | $2.47 Million | ▼ -51.5% |
| 1998 | -2.28x | $-8.90 Million | $3.90 Million | ▼ -3.7% |
| 1997 | -2.20x | $-7.70 Million | $3.50 Million | ▲ +63.7% |
| 1996 | -6.06x | $-9.70 Million | $1.60 Million | ▼ -91.9% |
| 1995 | -3.16x | $-7.90 Million | $2.50 Million | ▼ -7.6% |
| 1994 | -2.94x | $-9.10 Million | $3.10 Million | ▼ -113.5% |
| 1993 | -1.38x | $-5.50 Million | $4.00 Million | ▲ +15.4% |
| 1992 | -1.63x | $-3.90 Million | $2.40 Million | ▼ -51.7% |
| 1991 | -1.07x | $-3.00 Million | $2.80 Million | ▲ +0.0% |
| 1990 | -1.07x | $-3.00 Million | $2.80 Million | ▼ -282.7% |
| 1989 | -0.28x | $-700.00K | $2.50 Million | ▼ -92.0% |
| 1988 | -0.15x | $-700.00K | $4.80 Million | ▼ -105.0% |
| 1986 | 2.93x | $12.30 Million | $4.20 Million | — |